A prospective evaluation of efficacy and safety of topical bromfenac 0.09% over topical flurbiprofen 0.03% after cataract surgery

Simple item page
dc.contributor.authorHebbar, Sahana K.en_US
dc.contributor.authorP., Deepaken_US
dc.contributor.authorG. K., Nalinien_US
dc.contributor.authorC. V., Kavithaen_US
dc.contributor.authorG. N., Sahanaen_US
dc.contributor.authorNagaral, Jayashree V.en_US
dc.date.accessioned2020-04-23T07:53:54Z
dc.date.available2020-04-23T07:53:54Z
dc.date.issued2019-02
dc.description.abstractBackground: Different medications are used to reduce pain and inflammation after cataract surgery. Hence this study was taken up to compare the efficacy and safety of topical bromfenac 0.09% over topical flurbiprofen 0.03% in reducing anterior chamber inflammation and pain after cataract surgery.Methods: Total of 100 patients who underwent uneventful cataract surgery with posterior chamber intra ocular lens (IOL) implantation were randomly allocated to receive bromfenac 0.09% and flurbiprofen 0.03% topically from first post-operative day onwards for 6 weeks. Assessment of anterior chamber inflammation and pain was done by slit lamp and visual analogue scale respectively on each follow up days. Analysis was done by unpaired t test and Fischer’s exact test.Results: The response to treatment was earlier in bromfenac group for all the inflammatory changes (significant difference was found on day 7, p<0.05) except for corneal edema where both the groups showed similar response. On 7th day after surgery, 72% patients in flurbiprofen group and 12% in bromfenac group had pain (score1), while on the 14th day none in the bromfenac group complained of pain whereas 4% in flurbiprofen group still had pain. Both the drugs were safe and no clinically serious adverse effects were observed in either of the groups.Conclusions: This study showed both the medications, topical bromfenac 0.09% and topical flurbiprofen 0.03% effective and safe in reducing pain and anterior chamber inflammation after cataract surgery but the response was earlier with bromfenac 0.09%.en_US
dc.identifier.affiliationsDepartment of Pharmacology, HIMS, Hassan, Karnataka, Indiaen_US
dc.identifier.affiliationsDepartment of Ophthalmology, HIMS, Hassan, Karnataka, Indiaen_US
dc.identifier.citationHebbar Sahana K., P. Deepak, G. K. Nalini, C. V. Kavitha, G. N. Sahana, Nagaral Jayashree V.. A prospective evaluation of efficacy and safety of topical bromfenac 0.09% over topical flurbiprofen 0.03% after cataract surgery. International Journal of Basic & Clinical Pharmacology. 2019 Feb; 8(2): 234-239en_US
dc.identifier.issn2319-2003
dc.identifier.issn2279-0780
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/200004
dc.languageenen_US
dc.publisherMedip Academyen_US
dc.relation.issuenumber2en_US
dc.relation.volume8en_US
dc.source.urihttps://dx.doi.org/10.18203/2319-2003.ijbcp20190140en_US
dc.subjectAnterior chamber inflammationen_US
dc.subjectBromfenacen_US
dc.subjectFlurbiprofenen_US
dc.subjectPost-operative painen_US
dc.subjectProstaglandinsen_US
dc.titleA prospective evaluation of efficacy and safety of topical bromfenac 0.09% over topical flurbiprofen 0.03% after cataract surgeryen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijbcp2019v8n2p234.pdf
Size:
199.2 KB
Format:
Adobe Portable Document Format
Download
Collections
International Journal of Basic & Clinical Pharmacology